About Technology Issues FAQ

Links

Official Page

Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial

Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.